Xuekang Cai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xuekang Cai has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Jingming Zhang
Department of Nuclear Medicine, Peking University First Hospital, Beijing 100034, China
1 shared publication - Kun Wang
Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital Southern Medical University Guangzhou Guangdong China
1 shared publication - Shuixing Zhang
Department of Radiology, The First Affiliated Hospital of Jinan University, Guangzhou, China
1 shared publication - Wei Li
Medical Imaging Center, the First Affiliated Hospital, Jinan University, Guangzhou 510630, China
1 shared publication - Wenhui Huang
College of Medicine and Biological Information Engineering, Northeastern University, Shenyang 110167, China
1 shared publication - Zicong He
Medical Imaging Center, the First Affiliated Hospital, Jinan University, Guangzhou 510630, China
1 shared publication
Latest Publications
- Open Access
- 5 September 2022
- Published by MDPI AG in Biosensors
- Vol. 12 (9) , 729
The Dual-Targeted Peptide Conjugated Probe for Depicting Residual Nasopharyngeal Carcinoma and Guiding Surgery
Detecting residual nasopharyngeal carcinoma (rNPC) can be difficult because of the coexistence of occult tumours and post-chemoradiation changes, which poses a challenge for both radiologists and surgeons using current imaging methods. Currently, molecular imaging that precisely targets and visualises particular biomarkers in tumours may exceed the specificity and sensitivity of traditional imaging techniques, providing the potential to distinguish tumours from non-neoplastic lesions. Here, we synthesised a HER2/SR-BI-targeted tracer to efficiently position NPC and guide surgery in living mice. This bispecific tracer contained the following two parts: IRDye 800 CW, as an imaging reagent for both optical and optoacoustic imaging, and a fusion peptide (FY-35), as the targeting reagent. Both in vitro and in vivo tests demonstrated that the tracer had higher accumulation and longer retention (up to 48 h) in tumours than a single-targeted probe, and realised sensitive detection of tumours with a minimum size of 3.9 mm. By visualising the vascular network via a customised handheld optoacoustic scan, our intraoperative fluorescence molecular imaging system provides accurate guidance for intraoperative tumour resection. Integrating the advantages of both optical and optoacoustic scanning in an intraoperative image-guided system, this method holds promise for depicting rNPC and guiding salvage surgery.
- 5 September 2022
- Published by MDPI AG in Biosensors
- Vol. 12 (9) , 729
Open AccessThe Dual-Targeted Peptide Conjugated Probe for Depicting Residual Nasopharyngeal Carcinoma and Guiding Surgery
Detecting residual nasopharyngeal carcinoma (rNPC) can be difficult because of the coexistence of occult tumours and post-chemoradiation changes, which poses a challenge for both radiologists and surgeons using current imaging methods. Currently, molecular imaging that precisely targets and visualises particular biomarkers in tumours may exceed the specificity and sensitivity of traditional imaging techniques, providing the potential to distinguish tumours from non-neoplastic lesions. Here, we synthesised a HER2/SR-BI-targeted tracer to efficiently position NPC and guide surgery in living mice. This bispecific tracer contained the following two parts: IRDye 800 CW, as an imaging reagent for both optical and optoacoustic imaging, and a fusion peptide (FY-35), as the targeting reagent. Both in vitro and in vivo tests demonstrated that the tracer had higher accumulation and longer retention (up to 48 h) in tumours than a single-targeted probe, and realised sensitive detection of tumours with a minimum size of 3.9 mm. By visualising the vascular network via a customised handheld optoacoustic scan, our intraoperative fluorescence molecular imaging system provides accurate guidance for intraoperative tumour resection. Integrating the advantages of both optical and optoacoustic scanning in an intraoperative image-guided system, this method holds promise for depicting rNPC and guiding salvage surgery.